Thompson Davis & Co’s Aspen Aerogels ASPN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-24,150
Closed -$381K 123
2023
Q4
$381K Buy
24,150
+3,100
+15% +$32K 0.32% 46
2023
Q3
$181K Buy
21,050
+5,100
+32% +$36.2K 0.22% 76
2023
Q2
$126K Sell
15,950
-400
-2% -$2.78K 0.14% 98
2023
Q1
$122K Buy
+16,350
New +$163K 0.16% 89
2022
Q1
Sell
-10,200
Closed -$508K 108
2021
Q4
$508K Buy
+10,200
New +$537K 0.42% 38
2014
Q4
Sell
-250
Closed -$3K 1171
2014
Q3
$3K Buy
+250
New +$2.53K ﹤0.01% 987

Other funds holding ASPN

Thompson Davis & Co's ASPN Position: Q1 2024 in Review

Thompson Davis & Co sold out of Aspen Aerogels (ASPN) in Q1 2024, closing a stake of 24,150 shares — an estimated $381K sold.

Thompson Davis & Co first reported a position in ASPN in Q3 2014 and held it in 6 quarters. The position peaked at $508K in Q4 2021. 167 funds tracked by Wall St. Rank hold ASPN as of Q1 2024.

  • Thompson Davis & Co reported no remaining Aspen Aerogels position as of Q1 2024 after selling out during the quarter.
  • Thompson Davis & Co sold 24,150 Aspen Aerogels shares in Q1 2024, an estimated $381K.
  • Thompson Davis & Co first reported a position in Aspen Aerogels in Q3 2014 and held it in 6 quarters.
  • Thompson Davis & Co's Aspen Aerogels position peaked at $508K in Q4 2021.
  • 167 funds tracked by Wall St. Rank held Aspen Aerogels as of Q1 2024.

Based on Thompson Davis & Co's 13F filing for Q1 2024, filed 2 May 2024.